| A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors (NCT06234423) | OnCusp Therapeutics, Inc. | 2024-02-09 |
| A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia (NCT06113289) | M.D. Anderson Cancer Center | 2024-02-08 |
| A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors (NCT06285097) | Pfizer | 2024-02-08 |
| A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam (NCT06256510) | Pfizer | 2024-02-08 |
| Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions (NCT06192589) | Food and Drug Administration (FDA) | 2024-02-08 |
| Study Evaluating PRO-232 an Ophthalmic Solution Compared to Placebo. (NCT06352541) | Laboratorios Sophia S.A de C.V. | 2024-02-08 |
| CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT06128044) | Caribou Biosciences, Inc. | 2024-02-08 |
| T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma (NCT06157541) | Queensland Institute of Medical Research | 2024-02-08 |
| ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants (NCT06293742) | Eccogene | 2024-02-08 |
| FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae (NCT05791396) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2024-02-08 |
| The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer (NCT05735028) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-02-07 |
| Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects (NCT06195319) | Cassava Sciences, Inc. | 2024-02-07 |
| Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect (NCT06265532) | Hal Chapman | 2024-02-07 |
| Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ (NCT06218303) | Finn, Olivera, PhD | 2024-02-07 |
| Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors (NCT06177171) | Varun Monga, MBBS | 2024-02-07 |
| Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride (NCT05941429) | Cairo University | 2024-02-07 |
| A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants (NCT06316973) | Clear Scientific, Inc. | 2024-02-07 |
| A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma (NCT06326502) | Etnova Therapeutics Corp. | 2024-02-07 |
| A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058) (NCT06811246) | Merck Sharp & Dohme LLC | 2024-02-07 |
| A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies (NCT06045910) | Cancer Research UK | 2024-02-07 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414 (NCT06525168) | Chendu DIAO Nine Hong Pharmaceutical Factory | 2024-02-06 |
| TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) (NCT06169722) | Beijing Tide Pharmaceutical Co., Ltd | 2024-02-06 |
| A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors (NCT06158958) | AbbVie | 2024-02-06 |
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma (NCT05711615) | National Cancer Institute (NCI) | 2024-02-06 |
| ECC5004 RBA FE Study in Healthy Participants (NCT06268145) | Eccogene | 2024-02-06 |
| A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01 (NCT06247345) | Alzheimer's Disease Expert Lab (ADEL), Inc. | 2024-02-06 |
| Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype (NCT06247670) | CAMP4 Therapeutics Corporation | 2024-02-05 |
| The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART) (NCT06062966) | Virginia Commonwealth University | 2024-02-05 |
| QTX3034 in Patients With KRAS G12D Mutation (NCT06227377) | Quanta Therapeutics | 2024-02-05 |
| Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib (NCT06250205) | NewAmsterdam Pharma | 2024-02-05 |
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars (NCT06257355) | Claris Biotherapeutics, Inc. | 2024-02-05 |
| T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT05894824) | Yonsei University | 2024-02-05 |
| Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects (NCT06265012) | Public Health Vaccines LLC | 2024-02-05 |
| A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers (NCT05910827) | Hummingbird Bioscience | 2024-02-05 |
| CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. (NCT06231368) | Institute of Hematology & Blood Diseases Hospital, China | 2024-02-04 |
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers (NCT06169579) | Shenzhen NewDEL Biotech, Co., Ltd | 2024-02-04 |
| Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation (NCT06243354) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-02-04 |
| Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs. (NCT03591302) | Stephan Busque | 2024-02-02 |
| Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) (NCT06097468) | University of California, San Francisco | 2024-02-02 |
| A Clinical Trial of TQH3906 Capsules in Healthy Volunteers (NCT06230588) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-02-02 |
| Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas (NCT06253234) | Beijing Tiantan Hospital | 2024-02-02 |
| Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation (NCT06244719) | University of Colorado, Denver | 2024-02-02 |
| A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healthy Male Participants (NCT06227975) | Celgene | 2024-02-02 |
| A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age (NCT06222892) | Bellus Health Inc. - a GSK company | 2024-02-02 |
| Green Banana Peel Extract for Stasis Dermatitis Treatment (NCT06427733) | Universidade do Vale do Sapucai | 2024-02-02 |
| Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus (NCT06333483) | Autolus Limited | 2024-02-02 |
| Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke (NCT06365099) | University of Texas at Austin | 2024-02-02 |
| Study SC-101 in Subjects With Advanced Malignancies (NCT06220838) | Tianjin ConjuStar Biologics Co., Ltd. | 2024-02-02 |
| Efficacy of a Herbal Formula for Bone Metastases (NCT06023420) | Chinese University of Hong Kong | 2024-02-01 |
| Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative Study (NCT05923996) | Assiut University | 2024-02-01 |
| Safety and Tolerability Evaluationof Phascolarcobacterium Faecium (NCT07285317) | Spanish National Research Council | 2024-02-01 |
| Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) (NCT06352281) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-02-01 |
| Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients (NCT06265077) | Noha Mansour | 2024-02-01 |
| Treatment of Topical Ketorolac Gel in Acute Gouty Flare (NCT06273813) | Novilla Pharmaceuticals | 2024-02-01 |
| Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients (NCT03947437) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2024-02-01 |
| Efficacy of IVMED-85 on Pediatric Myopia (NCT05761795) | iVeena Delivery Systems, Inc. | 2024-02-01 |
| A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults (NCT06172348) | Pfizer | 2024-02-01 |
| A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells (NCT05344521) | Hamilton Health Sciences Corporation | 2024-02-01 |
| Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control (NCT06523504) | Ruihua Wei | 2024-02-01 |
| A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough (NCT06213363) | Beijing Tide Pharmaceutical Co., Ltd | 2024-02-01 |
| SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion (NCT06215170) | SafeMedWaste, Inc. | 2024-02-01 |
| Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics (NCT05534620) | medac GmbH | 2024-02-01 |
| Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure (NCT06002841) | D'Or Institute for Research and Education | 2024-02-01 |
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor (NCT06478251) | TingBo Liang | 2024-02-01 |
| Phase I Study of LNF1901 in Advanced Malignant Tumors (NCT06226363) | Shandong New Time Pharmaceutical Co., LTD | 2024-02-01 |
| Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors (NCT06221774) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-02-01 |
| Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT (NCT06062745) | Brigham and Women's Hospital | 2024-02-01 |
| The Efficacy of Scalp Block in Craniotomy (NCT06951230) | Ain Shams University | 2024-02-01 |
| Good Nights Sleep Program to Improve Child and Family Sleep (NCT06249217) | Auburn University | 2024-02-01 |
| Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS (NCT03696485) | Stem Cell Medicine Ltd. | 2024-02-01 |
| Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers (NCT06188624) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-02-01 |
| Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects (NCT05964647) | University Hospital, Basel, Switzerland | 2024-02-01 |
| NTI164 Human PK Study (NCT06713447) | Fenix Innovation Group | 2024-02-01 |
| Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser (NCT06239324) | Egymedicalpedia | 2024-02-01 |
| A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors (NCT06235541) | Genome & Company | 2024-02-01 |
| Reduction of Dentine Hypersensitivity After Use of Different Dentifrices (NCT06273930) | Armed Forces Institute of Dentistry, Pakistan | 2024-02-01 |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis (NCT06811025) | Beijing Chest Hospital | 2024-02-01 |
| Palbociclib and Pembrolizumab in Sarcoma (NCT06113809) | John Rieth | 2024-02-01 |
| Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection (NCT06370884) | University of Minnesota | 2024-02-01 |
| Phase I Study of XZ120 in Malignant Tumors (NCT06206915) | Shandong New Time Pharmaceutical Co., LTD | 2024-02-01 |
| Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging (NCT06271408) | Polarean, Inc. | 2024-02-01 |
| Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) (NCT07607197) | Hospital Universitari Vall d'Hebron Research Institute | 2024-02-01 |
| A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults (NCT06267963) | Pfizer | 2024-01-31 |
| Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels (NCT06516861) | Arsil Radiansyah | 2024-01-31 |
| Study of AZD9829 in CD123+ Hematological Malignancies (NCT06179511) | AstraZeneca | 2024-01-31 |
| Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA (NCT06091085) | Brigham and Women's Hospital | 2024-01-31 |
| PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications (NCT06161519) | National Cancer Institute (NCI) | 2024-01-31 |
| A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors (NCT06237881) | M.D. Anderson Cancer Center | 2024-01-31 |
| A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor (NCT06758557) | Huabo Biopharm Co., Ltd. | 2024-01-31 |
| Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease (NCT05340426) | University of Alabama at Birmingham | 2024-01-31 |
| AMT-253 in Patients With Advanced Solid Tumours (NCT06209580) | Multitude Therapeutics Inc. | 2024-01-31 |
| Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis (NCT06811012) | Beijing Chest Hospital | 2024-01-31 |
| A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) (NCT06114056) | West China Hospital | 2024-01-31 |
| Sonodynamic Therapy in Patients With Recurrent GBM (NCT06039709) | Shayan Moosa, MD | 2024-01-31 |
| A Trial of HS-10511 in Healthy Subjects (NCT06210607) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-01-31 |
| Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers (NCT06205381) | Aeovian Pharmaceuticals, Inc. | 2024-01-31 |
| TmPSMA-02 in mCRPC (NCT06046040) | University of Pennsylvania | 2024-01-31 |
| Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin (NCT05375825) | National Cancer Institute (NCI) | 2024-01-31 |
| Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care (NCT04824144) | Bruyère Health Research Institute. | 2024-01-30 |
| A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) (NCT06136598) | Merck Sharp & Dohme LLC | 2024-01-30 |